Who We Are

BeyondSpring is a Global, Clinical-Stage
Bio-pharmaceutical Company

Developing Innovative Immuno-Oncology Cancer Therapies with a Robust Pipeline from Internal Development and from Collaboration with the University of Washington in De Novo Drug Discovery Using a Ubiquitination Platform.